{
  "ticker": "LLY",
  "target_date": "2025-09-16",
  "actual_date": "2025-09-16",
  "collected_at": "2025-12-08T12:17:13.129447",
  "price": {
    "open": 744.32,
    "high": 769.25,
    "low": 743.45,
    "close": 763.588623046875,
    "volume": 3881300,
    "change_1d_pct": 2.21,
    "change_7d_pct": 5.16,
    "change_30d_pct": -0.34
  },
  "technicals": {
    "rsi_14": 66.99,
    "sma_20": 732.51,
    "sma_50": 739.39,
    "macd": 8.397,
    "macd_signal": 3.782,
    "macd_histogram": 4.615,
    "bb_upper": 771.69,
    "bb_lower": 693.34,
    "price_vs_sma20_pct": 4.24,
    "price_vs_sma50_pct": 3.27,
    "volume_ratio": 1.1
  },
  "fundamentals": {
    "market_cap": 892597501952,
    "pe_ratio": 48.784664,
    "forward_pe": 43.940643,
    "price_to_book": 37.488518,
    "price_to_sales": 15.021887,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.46,
    "pct_from_52w_low": 59.62
  },
  "macro": {
    "spy": {
      "price": 658.18,
      "change_1d_pct": -0.14,
      "change_7d_pct": 1.72
    },
    "vix": {
      "level": 16.36,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.03
    },
    "dollar_index": {
      "level": 96.63
    },
    "gold": {
      "price": 3688.9
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Why Eli Lilly Stock Was a Winner Today",
      "source": "Yahoo",
      "datetime": 1758064523,
      "summary": "A news article implied that the company might have an advantage in the weight loss drug race.",
      "url": "https://finnhub.io/api/news?id=b3cddc5cada1b96c35e68d2247b85a445f4566fcb0e1d5a57f38bb2bdd3b7d7c"
    },
    {
      "headline": "Lilly's oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine",
      "source": "Yahoo",
      "datetime": 1758063660,
      "summary": "Eli Lilly and Company (NYSE: LLY) today announced detailed results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron, an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist, in adults with obesity, or overweight with a weight-related medical proble",
      "url": "https://finnhub.io/api/news?id=546c1aeb7a6a2928dc4fa07526e6e35a6de4e2c4b41ffa14252bc9d290988648"
    },
    {
      "headline": "Why the Market Dipped But Eli Lilly (LLY) Gained Today",
      "source": "Yahoo",
      "datetime": 1758062704,
      "summary": "Eli Lilly (LLY) concluded the recent trading session at $763.57, signifying a +2.06% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=01bbd0bac03f99158261b2a0e0b02b6d06865dc7dae13bc8e25a1f039386a508"
    },
    {
      "headline": "Stocks to Watch Recap: Hershey, Oracle, New York Times",
      "source": "Yahoo",
      "datetime": 1758057070,
      "summary": "\u2197\ufe0fHershey (HSY): Shares in the chocolate maker rose 4.3% after Goldman Sachs upgraded its recommendation on the shares to buy from sell. \u2198\ufe0f Hims & Hers (HIMS): Shares of the telehealth platform dropped 5.",
      "url": "https://finnhub.io/api/news?id=654e2c1c633b1bbb8438213657b73e74bbffa574a29e558e1ff849e90c9efbb2"
    },
    {
      "headline": "Sector Update: Health Care Stocks Mixed Late Afternoon",
      "source": "Yahoo",
      "datetime": 1758056411,
      "summary": "Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index adding 0.3% an",
      "url": "https://finnhub.io/api/news?id=d61bd41738d0865bd4bd859b7d62e736c49dd77d6620765e52e0591690fe6917"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-08",
      "description": "xslF345X05/wk-form4_1757362781.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000238/xslF345X05/wk-form4_1757362781.xml"
    },
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412129.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000236/xslF345X05/wk-form4_1756412129.xml"
    },
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412046.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000234/xslF345X05/wk-form4_1756412046.xml"
    },
    {
      "form": "8-K",
      "date": "2025-08-20",
      "description": "d929636d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312525184093/d929636d8k.htm"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634987.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000232/xslF345X05/wk-form4_1755634987.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}